South Korea’s test kit developer Genematrix said on Tuesday it has signed a contract to provide its COVID-19 detection tests to the UNICEF, the United Nations International Children`s Emergency Fund. The contract for the supply of NeoPlexTM COVID-19 Detection Kit will run for up to two years.

The U.S. Food and Drug Administration granted Emergency Use Authorization to the product in May.

The company has collaborated with Center for Global Public Procurement under Korea Advanced Institute of Science and Technology (KAIST) by joining a state project to support overseas public procurement for private companies since April.

Currently, the NeoPlex COVID-19 kit is being exported to the U.S., Europe, South America, the Middle East, and Asia.

Another kit maker Midas AI said on Tuesday it has signed an exclusive agreement with Philosys Healthcare to sell the latter’s sampling kits and COVID-19 detection kits across Africa and Brazil.

Philosys Healthcare is producing interpedently developed antigen detection kit Gmate COVID-19 and sampling kit Universal Transport Medium. Gmate COVID-19 is characterized by rapid diagnosis of less than 20 minutes and high portability thanks to a built-in battery system. Universal Transport Medium is the first Korean sampling kit approved by the FDA.

By Pulse

[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]